MARKET

PRGO

PRGO

Perrigo Co Plc
NYSE
28.07
+0.13
+0.47%
After Hours: 28.09 +0.02 +0.06% 17:39 07/25 EDT
OPEN
27.99
PREV CLOSE
27.94
HIGH
28.40
LOW
27.84
VOLUME
1.36M
TURNOVER
0
52 WEEK HIGH
40.28
52 WEEK LOW
24.82
MARKET CAP
3.83B
P/E (TTM)
-479.8291
1D
5D
1M
3M
1Y
5Y
1D
Perrigo Company: A Strong Buy on Robust Brand Growth and Strategic Retail Expansion
TipRanks · 2d ago
O'Keefe Stevens Advisory Q2 2024 Investor Letter
Continued hopes of rate cuts drove a 3.9% gain in the S&P 500 in Q2. We initiated two new positions during the quarter: Alibaba and Perrigo. The A.I. Rally broadened beyond the obvious players of Nvidia, AMD, and Qualcomm.
Seeking Alpha · 3d ago
Weekly Report: what happened at PRGO last week (0715-0719)?
Weekly Report · 4d ago
Perrigo to Release Second Quarter 2024 Financial Results on August 2, 2024
Perrigo Company plc plans to issue its second quarter 2024 financial results on August 2, 2024. The earnings conference call will be available live via webcast to interested parties. Perrigo is a leading provider of Consumer Self-Care Products and over-the-counter health and wellness solutions.
PR Newswire · 07/19 13:15
5 Dividend Aristocrats Where Analysts See Capital Gains
NASDAQ · 07/15 12:37
Weekly Report: what happened at PRGO last week (0708-0712)?
Weekly Report · 07/15 09:14
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
AbbVie has petitioned the U.S. Supreme Court to protect its corporate records. The pharmaceutical company says a lower court ruling threatens the confidentiality of attorney communications. The case stems from allegations of overcharging for testosterone replacement drug AndroGel in Philadelphia.
Benzinga · 07/12 17:39
Perrigo Is Maintained at Overweight by Piper Sandler
Dow Jones · 07/11 12:04
More
About PRGO
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.

Webull offers Perrigo Company PLC stock information, including NYSE: PRGO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PRGO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PRGO stock methods without spending real money on the virtual paper trading platform.